Quality data.
Only comes with quality endpoints. This look at the 214 oncology drugs approved by the FDA from 2006-2017 shows only 7 (3%) demonstrated clinically meaningful improvements in quality of life beyond other clinical endpoints at time of approval. | Arciero, JAMA Netw Open 2021
The method of execution is really impressive of writers of this blog. This team does really work hard and brings new information to its readers. I am connected with this blog very long and I am really thankful kubet lua dao
ReplyDelete